Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

From left (top), Tedros Adhanom Ghebreyesus, Flavia Bustreo, Philippe Douste-Blazy, (bottom) David Nabarro, Sania Nishtar and Miklós Szócska

Q&A: WHO director-general candidates’ views on global healthSubscription

By

Six candidates in the race to be director-general of the World Health Organization outline their priorities and vision for global health.

Donald Trump during his acceptance speech as the Republican candidate for the US presidency

What impact president-elect Donald Trump will have on the US healthcare systemSubscription

By

William Seligman takes a look at what might happen to the US healthcare system and pharma under a Trump presidency.

Maree Todd, member of the Scottish Parliament and pharmacist

Q&A: From pharmacy to the Scottish Parliament — interview with MSP Maree ToddSubscription

By

Maree Todd, pharmacist and member of the Scottish Parliament, speaks to Jenny Bryan about the successes of community pharmacy in Scotland, what can England learn from them and her life in politics so far.

Illustration of a person cutting a pharmacy price tag

Q&A: Community pharmacy funding cuts in England – views from the front lineSubscription

By

In light of the government’s intention to cut funding for the sector and reform the remuneration structure, we asked four people from four different community pharmacy backgrounds to share their views.

Illustration showing that healthcare professionals and organisations must talk in order to get the best value for money when it comes to NHS funding

UK drug funding framework needs an overhaul to ensure the right areas are being prioritisedSubscription

By ,

If the NHS is to get value for money from medicines, it needs to consider what the UK population values and where its priorities lie.

Tim Evans is the senior director of health, nutrition and population at the World Bank Group

Q&A: World Bank warns that inaction on antimicrobial resistance could increase healthcare costs in developing countriesSubscription

By

Tim Evans from the World Bank Group talks about new research that shows how inaction on antimicrobial resistance could wipe out decades of healthcare gains and dramatically increase healthcare costs in developing countries.

Illustration showing the two sides of clinical pharmacy: medicines optimisation and patient care and well-being

Defining clinical pharmacy: a new paradigm Subscription

By , ,

Amid the rapid change and evolution of pharmacy, now is the time to redefine what clinical pharmacy means.

Paul Gallagher, head of the Royal College of Surgeons in Ireland’s School of Pharmacy

Q&A: From training surgeons in Ireland to providing healthcare education internationallySubscription

By

Paul Gallagher, head of the school of pharmacy at the Royal College of Surgeons in Ireland, speaks to Benedict Lam about how the royal college focus on education and training led to the expansion of its provision of healthcare education in Ireland and beyond.

Pharmacy research in the dictionary

Time to redefine pharmacy researchSubscription

By

There is no universal definition of pharmacy research, and this may be one of the reasons for poor quality research in the sector.

Nicola Magrini, secretary of the WHO expert committee on the selection and use of essential medicines

Q&A: Increasing global access to medicines for non-communicable diseasesSubscription

By

Nicola Magrini from the World Health Organization discusses improving access to affordable medicines for non-communicable diseases and warns that treatments for cancer lag behind.

Map showing connection points

High street pharmacies and opticians should work together to help manage minor eye conditions

By

Pharmacists and opticians should work together to better manage patients with dry eye within primary care, with one local scheme serving as a model for pharmacists to refer patients to opticians when necessary.

Hospital pharmacists working in office

Non-patient facing roles in hospital pharmacy are just as vital as patient facing onesSubscription

By

Roles such as procurement are important in hospital pharmacy services and should not be brushed aside.

Luiz Loures is deputy executive director of programme at the Joint United Nations Programme on HIV/AIDS (UNAIDS)

Ending the AIDS epidemic by 2030: can it be done?Subscription

By

Luiz Loures from the Joint United Nations Programme on HIV/AIDS (UNAIDS) talks about ending the epidemic, and the challenges in fighting the disease that has claimed over 34 million lives.

Sharing best practice globe

Challenges of sharing pharmacy best practice internationallySubscription

By

There are many barriers to overcome to ensure best practice is shared more widely on an international level.

Katherine Murphy, pictured, chief executive of the Patients Association, discusses the current crisis in the NHS and where pharmacists fit in to help, and explains why safety and transparency in the NHS are key priorities for the association in 2016

Q&A: What do patients want from pharmacists and the NHS?Subscription

By

Katherine Murphy discusses the current crisis gripping the NHS and where pharmacists can fit in to help, and explains why safety, accountability and transparency are key priorities for the NHS.

A prism refracts white light into different colours, representing how disclosure of information leads towards transparency

How full disclosure of clinical trial data will benefit the pharmaceutical industrySubscription

By

Disclosing clinical trial data is a step in the right direction towards transparency, which benefits both the public and the pharmaceutical industry.

V Craig Jordan, the scientist who discovered the role of tamoxifen in breast cancer

Q&A: V Craig Jordan — the father of tamoxifenSubscription

By

V Craig Jordan, Dallas/Fort Worth living legend chair of cancer research, professor of both breast medical oncology and molecular and cellular oncology at the University of Texas MD Anderson Cancer Center in Houston, is best known as “the father of tamoxifen”.

View of an exit door in a hospital setting

How the exit of the UK from the European Union could affect healthcare, science and research

By ,

Should the UK remain a member of the European Union or should it leave? We put two opposing views together to help you decide. 

E-cigarette on top of a broken traditional cigarette

Pharmacists must retain healthy scepticism about e-cigarettesSubscription

By

Why e-cigarettes must not divert our focus from nicotine prevention and cessation.

James Pound, editor-in-chief of the British Pharmacopoeia (BP)

Q&A: Providing official standards for UK medicines and pharmaceutical substances — the British PharmacopoeiaSubscription

By

James Pound, editor-in-chief of the British Pharmacopoeia (BP), explains how the BP is evolving to meet the changing needs of its many users and discusses how it compares and harmonises with other pharmacopoeias worldwide.

More comment

Simon Redman, director of finance at the Royal Pharmaceutical Society (RPS)

Q&A: An insight into the finances of the Royal Pharmaceutical SocietySubscription

By

The 2017 Royal Pharmaceutical Society (RPS) budget, agreed in November 2016, includes a financial surplus of £5,000 before interest. Here Simon Redman, director of finance at the RPS, talks to Julia Robinson about how the RPS has recovered from last year’s budgeted loss of £1.5m and what plans are being made to improve services and engage with members in the coming year. 

Doctor speaking to patient and social worker taking an elderly woman's blood pressure

Health and social care needs to be better integratedSubscription

By

Sandra Gidley, chair of the RPS English Pharmacy Board, makes the case for the integration of health and social care funding and explains why pharmacists are needed across the entire health and social care system and at all levels of the NHS.

Imagery of mental illness: woman sits on stairs looking out to sea

What can pharmacists do to improve the physical health of people with mental illness?Subscription

By , Dolly Sud

David Branford, member of the Royal Pharmaceutical Society (RPS) English Pharmacy Board, and Dolly Sud, specialist mental health pharmacist Leicestershire Partnership NHS Trust, explain the importance of the role of pharmacists in improving the physical well-being of patients with severe mental illness.

Illustration showing icons on long-term conditions and pharmacy

Pharmacists can help improve the care of patients with long-term conditions across Great BritainSubscription

By , Suzanne Scott-Thomas, John McAnaw

On 3 November 2016, the RPS launched its campaign on long-term conditions. Here, the chairs of the three RPS national pharmacy boards highlight the significance of the campaign and how it needs to be actioned in their respective countries. 

Claire Anderson, Royal Pharmaceutical Society (RPS) English Pharmacy Board vice chair

Why RPS members should attend the FIP World Congress of Pharmacy and Pharmaceutical SciencesSubscription

By

Royal Pharmaceutical Society (RPS) English Pharmacy Board vice chair, Claire Anderson, reflects on her experience of the 2016 International Pharmaceutical Federation World Congress and explains why she feels there is professional value in RPS members attending, particularly when it comes to Glasgow in 2018. 

Aileen Bryson, RPS Scotland’s practice and policy lead

What is the Falsified Medicines Directive? Subscription

By

Aileen Bryson, practice and policy lead at RPS Scotland, speaks to Julia Robinson about the purpose of the Falsified Medicines Directive and how it will affect pharmacists in the UK.

Naoko Arakawa, the international programme lead at the Royal Pharmaceutical Society (RPS)

Q&A: RPS international programme lead Naoko ArakawaSubscription

By

In 2015, the Royal Pharmaceutical Society signed an agreement with the Japanese Pharmaceutical Association promising to work together and share best practice on patient care and professional development. Here, Julia Robinson talks to Naoko Arakawa, the international programme lead at the RPS, about the collaboration so far. 

Aamer Safdar

Benchmarking will help hospital trusts meet Carter efficiency challengeSubscription

By

Member of the RPS English Pharmacy Board Aamer Safdar makes the case for using benchmarking to help realise savings in line with the Carter review.

Union Jack and EU flags illustration of Brexit

The future of the UK post-BrexitSubscription

By

Two months on from the referendum vote to exit the EU, English Pharmacy Board member Sid Dajani puts forward his ideas on the potential impact on medicine and what the RPS should be doing to minimise the fallout.

Martin Astbury, president of the Royal Pharmaceutical Society (RPS)

Q&A: New RPS president Martin AstburySubscription

By

Two years after he was succeeded by Ash Soni, recently affirmed RPS president and self-professed ‘Joe Bloggs pharmacist’ Martin Astbury says he has learnt from his four terms from 2010 to 2014 and is ready to serve the Society again.

Your RPS

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.